Aurora Cannabis Inc’s shares rose as the Alberta-based medical cannabis firm reaffirmed its aim to achieve positive free cash flow by the end of 2024. The company’s acquisition of MedReleaf Australia positions it as the largest global medical cannabis company. In the fiscal third quarter, revenue increased to C$66.4 million, with significant growth in medical cannabis revenue. CEO Miguel Martin highlighted the company’s focus on profitable global medical cannabis markets. Aurora aims to become debt-free later this month.
Read the full story here
Written by:
Published on February 9, 2024 at 03:47PM
Source: Proactiveinvestors UK (opens in new tab)